Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $2.4M | $47.4M | $39.5M | $24.2M | $41.7M | $2.5M | $500.0K | $325.0K |
| Cost of revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Gross profit | $2.4M | $47.4M | $39.5M | $24.2M | $41.7M | $2.5M | $500.0K | $325.0K |
| Gross margin | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
| R&D | $16.5M | $38.9M | $26.2M | $32.2M | $33.2M | $35.8M | $44.4M | $49.5M |
| Operating income | −$24.5M | −$2.1M | $1.9M | −$22.4M | −$4.3M | −$46.9M | −$58.5M | −$66.3M |
| EBITDA | −$24.5M | −$814.0K | $3.7M | −$20.1M | −$4.3M | −$46.9M | −$57.0M | −$64.8M |
| Net income | −$24.3M | −$1.4M | $407.0K | −$21.3M | −$2.0M | −$45.9M | −$57.8M | −$71.4M |
| Net margin | -1033.1% | -2.9% | 1.0% | -88.1% | -4.8% | -1870.9% | -11565.8% | -21976.6% |
| EPS (diluted) | -1.50 | -0.08 | 0.02 | -1.18 | -0.11 | -2.17 | -1.77 | -1.59 |
Annual figures · source: Financial Modeling Prep
No one on the platform currently holds AGTC.
No tracked institution reports a position in AGTC as of their last filing.
No one on the platform has traded AGTC yet.
| $22M |
| — |
| FRLNFreeline Therapeutics Holdings plc | $6.49 | +0.15% | $28M | — |
| HARPHarpoon Therapeutics, Inc. | $23.01 | +0.09% | $865M | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
$AGTC PDUFA 3/28/26 Rocket Pharmaceuticals announced that clinical results for KRESLADI™ (in treating severe Leukocyte Adhesion Deficiency-I (LAD-I) remain overwhelmingly positive, with the therapy achieving all primary and secondary endpoints in its registration-enabling study. Key Study Results The global Phase 1/2 clinical trial (NCT03812263) involved nine pediatric patients with severe LAD-I and yielded the following results: Survival Rate: 100% overall survival at 12 months post-infusion, which has been sustained for all patients throughout the entire follow-up period (ranging from 18 to 45 months). Infection Reduction: A substantial decrease in the incidence of significant infections compared to the patients' pre-treatment histories. Clinical Improvements: Evidence of resolution of LAD-I-related skin and periodontal lesions, along with the restoration of wound-healing capabilities. The therapy was well-tolerated with zero drug-related serious adverse events
View on StockTwits ↗$AGTC https://clarkstreetvalue.blogspot.com/2022/10/applied-genetic-technologies-no.html?m=1 Very good written
View on StockTwits ↗$AGTC Is there a time horizon on the CVR when they don't have to pay anything to us?
View on StockTwits ↗$AGTC here there ! does anyone have any updates on the CVR payments ? or did receive already some ? thanks!
View on StockTwits ↗@CABTC Please come check out @ $SPGC!! I have been following you since you told people about $MGOL $BHAT $AGTC $LICN Show a brother some love and take a few minutes, and check out $SPGC This is exactly what happened to MGOL before the rip!
View on StockTwits ↗$AGTC https://www.beacontx.com/news-and-events/beacon-therapeutics-announces-positive-24-month-data-from-phase-2-skyline-trial-of-agtc-501-in-patients-with-x-linked-retinitis-pigmentosa/ Looks like the CVRs aren’t dead yet.
View on StockTwits ↗$AGTC $AGTC how the fuq do I get this off my Robinhood account?
View on StockTwits ↗$AMD $ARM $NVDA $AMZN $AGTC The market has been completely dead ! No movement at all in either direction.... stagnant ! Market Manipulators keeping assets subdued ?
View on StockTwits ↗$AGTC, nadie nada del cobro de los hitos? yo intente buscar información y no encontré nada y me parece una vergüenza porque ya pasaron más de 18 meses y al menos deberían informarnos. Muchas gracias si alguien escribo por aquí si tiene alguna información.
View on StockTwits ↗$AGTC alguien sabe algo del pago del hito 1?
View on StockTwits ↗$AGTC Alguien sabe algo del cobro de los hitos? pasaron 18 meses, parece que todo va bien y entiendo que al menos deberíamos haber cobrado el hito 1 (1/4 de los 0,73 por CVR). Muchas gracias si alguien nos puede informar de como va todo y si empezaremos a cobrar los hitos.
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.